Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumours
G Scambia, F O Ranelletti, P Benedetti Panici, et al.
Journal of Clinical & Laboratory Immunology
|
October 1, 1986
Estrogen binding sites in peripheral blood mononuclear cells and thymocytes from 2 myasthenia gravis patients
A Carbone, M Piantelli, P Musiani, et al.
International Journal of Cancer
|
May 28, 1993
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines
G Scambia, F O Ranelletti, P B Panici, et al.
Gynecologic Oncology
|
April 1, 1993
Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptor
G Ferrandina, G Scambia, P Benedetti Panici, et al.
British Journal of Haematology
|
December 1, 1991
Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors
L M Larocca, L Teofili, G Leone, et al.
Journal of Neurosurgical Sciences
|
July 1, 1990
Type II estrogen binding sites (EBS) in intracranial tumors
A Capelli, M Piantelli, A Rinelli, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research
|
March 1, 1995
Sutureless anastomosis of the small intestine and the colon in pigs using an absorbable intraluminal stent and fibrin glue
M B Detweiler, V Durastante, A Verbo, et al.
British Journal of Cancer
|
May 14, 1998
Prognostic significance of methyl-p-hydroxy-phenyllactate-esterase activity in laryngeal squamous cell carcinoma
M Maurizi, G Ferrandina, G Almadori, et al.
Oncogenesis
|
September 2, 2014
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer
R Lattanzio, R Ghasemi, F Brancati, et al.
International Journal of Cancer
|
September 4, 1995
Methyl-p-hydroxyphenyllactate-esterase activity and type-II estrogen-binding sites in ovarian cancer: correlation with biological and clinico-pathological parameters
F O Ranelletti, G Scambia, P Benedetti Panici, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumours
G Scambia, F O Ranelletti, P Benedetti Panici, et al.
Journal of Clinical & Laboratory Immunology
|
October 1, 1986
Estrogen binding sites in peripheral blood mononuclear cells and thymocytes from 2 myasthenia gravis patients
A Carbone, M Piantelli, P Musiani, et al.
International Journal of Cancer
|
May 28, 1993
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines
G Scambia, F O Ranelletti, P B Panici, et al.
Gynecologic Oncology
|
April 1, 1993
Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptor
G Ferrandina, G Scambia, P Benedetti Panici, et al.
British Journal of Haematology
|
December 1, 1991
Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors
L M Larocca, L Teofili, G Leone, et al.
Journal of Neurosurgical Sciences
|
July 1, 1990
Type II estrogen binding sites (EBS) in intracranial tumors
A Capelli, M Piantelli, A Rinelli, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research
|
March 1, 1995
Sutureless anastomosis of the small intestine and the colon in pigs using an absorbable intraluminal stent and fibrin glue
M B Detweiler, V Durastante, A Verbo, et al.
British Journal of Cancer
|
May 14, 1998
Prognostic significance of methyl-p-hydroxy-phenyllactate-esterase activity in laryngeal squamous cell carcinoma
M Maurizi, G Ferrandina, G Almadori, et al.
Oncogenesis
|
September 2, 2014
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer
R Lattanzio, R Ghasemi, F Brancati, et al.
International Journal of Cancer
|
September 4, 1995
Methyl-p-hydroxyphenyllactate-esterase activity and type-II estrogen-binding sites in ovarian cancer: correlation with biological and clinico-pathological parameters
F O Ranelletti, G Scambia, P Benedetti Panici, et al.
Page
of 14